Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MLYS

Mineralys Therapeutics (MLYS)

Mineralys Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MLYS
DateTimeSourceHeadlineSymbolCompany
06/17/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
06/17/20244:31PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
06/14/20248:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
06/14/20248:00AMGlobeNewswire Inc.Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of DirectorsNASDAQ:MLYSMineralys Therapeutics Inc
06/10/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
05/31/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
05/23/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
05/22/20244:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
05/09/20247:10AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MLYSMineralys Therapeutics Inc
05/09/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
05/09/20247:00AMGlobeNewswire Inc.Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
05/06/20248:00AMGlobeNewswire Inc.Mineralys Therapeutics to Participate in the Bank of America Securities Health Care ConferenceNASDAQ:MLYSMineralys Therapeutics Inc
05/02/20248:00AMGlobeNewswire Inc.Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024NASDAQ:MLYSMineralys Therapeutics Inc
03/21/20247:00AMGlobeNewswire Inc.Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
03/13/20244:05PMGlobeNewswire Inc.Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024NASDAQ:MLYSMineralys Therapeutics Inc
02/15/20244:20PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MLYSMineralys Therapeutics Inc
02/08/20244:41PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
02/08/20248:00AMGlobeNewswire Inc.Mineralys Therapeutics Announces $120 Million Private Placement FinancingNASDAQ:MLYSMineralys Therapeutics Inc
01/29/20244:05PMGlobeNewswire Inc.Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology ConferenceNASDAQ:MLYSMineralys Therapeutics Inc
01/04/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
01/04/20244:05PMGlobeNewswire Inc.Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business OfficerNASDAQ:MLYSMineralys Therapeutics Inc
12/22/20239:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
12/21/20234:05PMGlobeNewswire Inc.Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of HypertensionNASDAQ:MLYSMineralys Therapeutics Inc
11/13/20238:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
11/11/202311:30AMGlobeNewswire Inc.Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023NASDAQ:MLYSMineralys Therapeutics Inc
11/09/20234:05PMGlobeNewswire Inc.Mineralys Therapeutics to Participate in Three Upcoming ConferencesNASDAQ:MLYSMineralys Therapeutics Inc
11/07/20235:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MLYSMineralys Therapeutics Inc
11/07/20234:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
11/07/20234:05PMGlobeNewswire Inc.Mineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
11/02/202310:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLYS

Your Recent History

Delayed Upgrade Clock